Literature DB >> 27456520

On Endogenous Angiotensin II Antagonism in Hypertension: The Role of Dipeptidyl Peptidase III.

María Paz Ocaranza1, Jorge E Jalil2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27456520     DOI： 10.1161/HYPERTENSIONAHA.116.07471

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

Review 1.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

2.  Translational proteomics in cardiogenic shock: from benchmark to bedside.

Authors:  Oriol Iborra-Egea; Antoni Bayes-Genis
Journal:  J Geriatr Cardiol       Date:  2022-02-28       Impact factor: 3.327

Review 3.  Perspectives on the Potential Benefits of Antihypertensive Peptides towards Metabolic Syndrome.

Authors:  Forough Jahandideh; Jianping Wu
Journal:  Int J Mol Sci       Date:  2020-03-22       Impact factor: 5.923

4.  Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101).

Authors:  Mahir Karakas; Dominik Jarczak; Martin Becker; Kevin Roedl; Marylyn M Addo; Frauke Hein; Andreas Bergmann; Jens Zimmermann; Tim-Philipp Simon; Gernot Marx; Marc Lütgehetmann; Axel Nierhaus; Stefan Kluge
Journal:  Biomolecules       Date:  2020-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.